ard
acut
respiratori
distress
syndrom
dhea
dehydroepiandrosteron
sulphat
nitric
oxid
search
marker
sepsi
inflamm
continu
perhap
find
may
abl
alter
influenc
underli
pathophysiolog
sepsi
mani
report
believ
may
lie
hypothalamicpituitaryadren
axi
recent
publish
manglik
colleagu
look
secondari
adrenocort
insuffici
patient
present
sever
sepsi
measur
maxim
cortisol
secret
stimul
adrenocorticotroph
hormon
investig
found
popul
fail
adrenocorticotroph
hormon
stimul
test
four
per
cent
previous
undiagnos
pituitari
diseas
suffer
sepsisrel
adren
dysfunct
use
absolut
cortisol
level
delta
cortisol
defin
adrenocort
insuffici
establish
definit
adrenocort
insuffici
sepsi
studi
continu
yield
dispar
result
look
reduc
endogen
steroid
level
sepsi
marx
cowork
focus
androgen
dehydroepiandrosteron
dhea
sulphat
precursor
dhea
look
dispar
survivor
nonsurvivor
sever
sepsi
cortisol
level
survivor
reach
upper
normal
limit
decreas
significantli
toward
late
sepsi
howev
nonsurvivor
persist
lower
cortisol
level
within
normal
physiolog
rang
throughout
sepsi
dhea
parallel
survivor
normal
earli
level
reduc
late
sepsi
nonsurvivor
level
persist
low
throughout
signific
degre
survivor
persist
elev
level
dhea
compar
nonsurvivor
marx
cowork
show
rel
adrenocort
insuffici
extend
androgen
dhea
dhea
chang
parallel
dhea
level
may
even
predict
surviv
sever
sepsi
apach
acut
physiolog
chronic
health
evalu
score
stress
dose
hydrocortison
attenu
sever
system
inflammatori
respons
syndrom
cardiac
surgeri
cardiopulmonari
bypass
kilger
cowork
would
suggest
highrisk
patient
found
sever
system
inflammatori
respons
syndrom
serum
concentr
pgml
best
predict
popul
bypass
time
excess
min
cardiac
eject
fraction
thu
target
predefin
highrisk
patient
receiv
hydrocortison
show
recipi
significantli
lower
level
reduc
durat
ventil
catecholamin
support
reduc
durat
stay
intens
care
unit
hospit
noth
yet
suggest
mortal
benefit
though
increas
tissu
factor
produc
part
septic
inflammatori
process
coagul
cascad
activ
carraway
cowork
alreadi
shown
pretreat
baboon
activ
siteinactiv
factor
vii
tissu
factor
pathway
inhibitor
onset
sepsi
attenu
organ
injuri
protect
lung
kidney
shown
similarli
block
tissu
factor
establish
gramneg
sepsi
attenu
damag
use
baboon
model
block
coagul
cascad
initi
use
activ
siteinactiv
factor
vii
time
first
antibiot
therapi
induc
sepsi
result
reduc
acut
lung
injuri
renal
injuri
metabol
acidosi
sepsisinduc
coagulopathi
manipul
therapeut
human
sepsi
time
research
tell
move
away
direct
involv
inflamm
coagul
process
soliman
colleagu
look
ioniz
portion
serum
magnesium
vari
critic
ill
found
ioniz
magnesium
level
present
affect
outcom
twothird
popul
normal
level
develop
reduc
level
ioniz
magnesium
intens
care
associ
higher
mortal
sever
organ
dysfunct
sepsi
independ
risk
factor
ioniz
hypomagnesaemia
soliman
colleagu
postul
prolong
diseas
diuret
administr
may
also
contributori
may
low
level
contribut
critic
ill
convers
true
true
unclear
need
discov
magnesium
supplement
alter
find
inappropri
ventilatori
strategi
patient
acut
respiratori
distress
syndrom
ard
may
consequ
recipi
lung
abnorm
imai
colleagu
indic
remot
cellular
damag
also
occur
may
contribut
multipl
organ
dysfunct
often
accompani
ard
look
endorgan
epitheli
cell
apoptosi
rabbit
model
ard
effect
plasma
epitheli
cell
recipi
injuri
ventilatori
strategi
analyz
sampl
previou
trial
lung
protect
ventil
show
kidney
small
intestin
damag
occur
ventil
high
tidal
volum
low
posit
endexpiratori
pressur
use
plasma
rabbit
group
would
induc
apoptosi
cell
vitro
fasfa
ligand
system
involv
cell
apoptosi
found
elev
level
solubl
fa
ligand
human
patient
receiv
protect
ventilatori
strategi
correl
well
elev
creatinin
level
choos
right
ventil
strategi
ard
patient
benefit
lung
protect
therapeut
target
factor
induc
end
organ
apoptosi
may
next
step
choos
right
ventil
strategi
may
way
avoid
lung
problem
patient
ard
desir
strategi
involv
prevent
overdistend
alveoli
derecruit
thu
unreason
consid
period
endotrach
suction
might
undermin
benefit
maggior
colleagu
set
find
whether
patient
acut
lung
injuri
consid
prevent
measur
found
close
suction
system
reduc
larg
lung
volum
fall
preserv
posit
endexpiratori
pressur
induc
recruit
recruit
augment
perform
recruit
manoeuvr
time
suction
repetit
shear
stress
alveoli
injuri
studi
show
way
prevent
use
inhal
nitric
oxid
patient
ard
improv
oxygen
proven
improv
outcom
gerlach
cowork
look
doserespons
characterist
longterm
use
found
characterist
chang
patient
could
becom
sensit
number
respond
low
dose
increas
becam
nonrespond
higher
dose
would
seem
constant
dose
right
patient
throughout
treatment
interpati
intrapati
doserespons
variabl
thought
titrat
dose
step
may
improv
longterm
benefit
therapi
respect
inotrop
one
use
debat
continu
de
backer
colleagu
compar
inotrop
effect
splanchnic
circul
sepsi
dopamin
use
substitut
either
adrenalin
epinephrin
noradrenalin
norepinephrin
achiev
maintain
adequ
arteri
pressur
depend
shock
sever
three
inotrop
compar
moder
shock
dopamin
would
actual
appear
modest
benefit
splanchnic
circul
howev
sever
septic
shock
adrenalin
impair
splanchnic
circul
de
backer
colleagu
suggest
avoid
high
dose
patient
larger
truli
random
trial
determin
whether
correct
howev
use
low
dose
dopamin
critic
ill
patient
renal
protect
holm
walley
tell
us
practic
releg
place
hightid
volum
ventil
liber
transfus
practic
